nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefprozil—Superinfection—Capecitabine—esophageal cancer	0.0796	0.0796	CcSEcCtD
Cefprozil—Tonsillitis—Capecitabine—esophageal cancer	0.0716	0.0716	CcSEcCtD
Cefprozil—Congenital anomaly—Capecitabine—esophageal cancer	0.0476	0.0476	CcSEcCtD
Cefprozil—Developmental delay—Capecitabine—esophageal cancer	0.0476	0.0476	CcSEcCtD
Cefprozil—Prothrombin level increased—Capecitabine—esophageal cancer	0.0441	0.0441	CcSEcCtD
Cefprozil—Pruritus genital—Capecitabine—esophageal cancer	0.0433	0.0433	CcSEcCtD
Cefprozil—Nephropathy toxic—Cisplatin—esophageal cancer	0.0427	0.0427	CcSEcCtD
Cefprozil—Pain—Carboplatin—esophageal cancer	0.0255	0.0255	CcSEcCtD
Cefprozil—Body temperature increased—Carboplatin—esophageal cancer	0.0236	0.0236	CcSEcCtD
Cefprozil—Haemolytic anaemia—Cisplatin—esophageal cancer	0.0197	0.0197	CcSEcCtD
Cefprozil—Colitis—Capecitabine—esophageal cancer	0.0174	0.0174	CcSEcCtD
Cefprozil—Pancytopenia—Cisplatin—esophageal cancer	0.0146	0.0146	CcSEcCtD
Cefprozil—Haemolytic anaemia—Capecitabine—esophageal cancer	0.0145	0.0145	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.0139	0.0139	CcSEcCtD
Cefprozil—Vaginal inflammation—Methotrexate—esophageal cancer	0.0135	0.0135	CcSEcCtD
Cefprozil—Vaginal infection—Methotrexate—esophageal cancer	0.0127	0.0127	CcSEcCtD
Cefprozil—Aplastic anaemia—Methotrexate—esophageal cancer	0.0126	0.0126	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.0118	0.0118	CcSEcCtD
Cefprozil—Pancytopenia—Capecitabine—esophageal cancer	0.0108	0.0108	CcSEcCtD
Cefprozil—Erythema—Cisplatin—esophageal cancer	0.0107	0.0107	CcSEcCtD
Cefprozil—Neutropenia—Capecitabine—esophageal cancer	0.0106	0.0106	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.0104	0.0104	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.01	0.01	CcSEcCtD
Cefprozil—Agranulocytosis—Capecitabine—esophageal cancer	0.00944	0.00944	CcSEcCtD
Cefprozil—Convulsion—Cisplatin—esophageal cancer	0.00929	0.00929	CcSEcCtD
Cefprozil—Haemoglobin—Capecitabine—esophageal cancer	0.00913	0.00913	CcSEcCtD
Cefprozil—Haemorrhage—Capecitabine—esophageal cancer	0.00908	0.00908	CcSEcCtD
Cefprozil—Pharyngitis—Capecitabine—esophageal cancer	0.00901	0.00901	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.0088	0.0088	CcSEcCtD
Cefprozil—Anaphylactic shock—Cisplatin—esophageal cancer	0.00875	0.00875	CcSEcCtD
Cefprozil—Erythema multiforme—Capecitabine—esophageal cancer	0.00859	0.00859	CcSEcCtD
Cefprozil—Thrombocytopenia—Cisplatin—esophageal cancer	0.00857	0.00857	CcSEcCtD
Cefprozil—Eosinophilia—Methotrexate—esophageal cancer	0.00836	0.00836	CcSEcCtD
Cefprozil—Pancytopenia—Methotrexate—esophageal cancer	0.00802	0.00802	CcSEcCtD
Cefprozil—Erythema—Capecitabine—esophageal cancer	0.0079	0.0079	CcSEcCtD
Cefprozil—Neutropenia—Methotrexate—esophageal cancer	0.0079	0.0079	CcSEcCtD
Cefprozil—Drowsiness—Methotrexate—esophageal cancer	0.00753	0.00753	CcSEcCtD
Cefprozil—Pain—Cisplatin—esophageal cancer	0.00748	0.00748	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00746	0.00746	CcSEcCtD
Cefprozil—Feeling abnormal—Cisplatin—esophageal cancer	0.00721	0.00721	CcSEcCtD
Cefprozil—Agranulocytosis—Methotrexate—esophageal cancer	0.00703	0.00703	CcSEcCtD
Cefprozil—Body temperature increased—Cisplatin—esophageal cancer	0.00692	0.00692	CcSEcCtD
Cefprozil—Haemoglobin—Methotrexate—esophageal cancer	0.00679	0.00679	CcSEcCtD
Cefprozil—Haemorrhage—Methotrexate—esophageal cancer	0.00676	0.00676	CcSEcCtD
Cefprozil—Pharyngitis—Methotrexate—esophageal cancer	0.00671	0.00671	CcSEcCtD
Cefprozil—Confusional state—Capecitabine—esophageal cancer	0.0065	0.0065	CcSEcCtD
Cefprozil—Hypersensitivity—Cisplatin—esophageal cancer	0.00645	0.00645	CcSEcCtD
Cefprozil—Erythema multiforme—Methotrexate—esophageal cancer	0.00639	0.00639	CcSEcCtD
Cefprozil—Thrombocytopenia—Capecitabine—esophageal cancer	0.00632	0.00632	CcSEcCtD
Cefprozil—Diarrhoea—Cisplatin—esophageal cancer	0.00599	0.00599	CcSEcCtD
Cefprozil—Erythema—Methotrexate—esophageal cancer	0.00588	0.00588	CcSEcCtD
Cefprozil—Insomnia—Capecitabine—esophageal cancer	0.00583	0.00583	CcSEcCtD
Cefprozil—Vomiting—Cisplatin—esophageal cancer	0.00556	0.00556	CcSEcCtD
Cefprozil—Rash—Cisplatin—esophageal cancer	0.00552	0.00552	CcSEcCtD
Cefprozil—Pain—Capecitabine—esophageal cancer	0.00552	0.00552	CcSEcCtD
Cefprozil—Dermatitis—Cisplatin—esophageal cancer	0.00551	0.00551	CcSEcCtD
Cefprozil—Feeling abnormal—Capecitabine—esophageal cancer	0.00532	0.00532	CcSEcCtD
Cefprozil—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00528	0.00528	CcSEcCtD
Cefprozil—Nausea—Cisplatin—esophageal cancer	0.0052	0.0052	CcSEcCtD
Cefprozil—Urticaria—Capecitabine—esophageal cancer	0.00512	0.00512	CcSEcCtD
Cefprozil—Abdominal pain—Capecitabine—esophageal cancer	0.0051	0.0051	CcSEcCtD
Cefprozil—Body temperature increased—Capecitabine—esophageal cancer	0.0051	0.0051	CcSEcCtD
Cefprozil—Convulsion—Methotrexate—esophageal cancer	0.0051	0.0051	CcSEcCtD
Cefprozil—Confusional state—Methotrexate—esophageal cancer	0.00484	0.00484	CcSEcCtD
Cefprozil—Anaphylactic shock—Methotrexate—esophageal cancer	0.0048	0.0048	CcSEcCtD
Cefprozil—Hypersensitivity—Capecitabine—esophageal cancer	0.00475	0.00475	CcSEcCtD
Cefprozil—Thrombocytopenia—Methotrexate—esophageal cancer	0.0047	0.0047	CcSEcCtD
Cefprozil—Pruritus—Capecitabine—esophageal cancer	0.00456	0.00456	CcSEcCtD
Cefprozil—Diarrhoea—Capecitabine—esophageal cancer	0.00441	0.00441	CcSEcCtD
Cefprozil—Insomnia—Methotrexate—esophageal cancer	0.00434	0.00434	CcSEcCtD
Cefprozil—Somnolence—Methotrexate—esophageal cancer	0.00427	0.00427	CcSEcCtD
Cefprozil—Dizziness—Capecitabine—esophageal cancer	0.00427	0.00427	CcSEcCtD
Cefprozil—Pain—Methotrexate—esophageal cancer	0.00411	0.00411	CcSEcCtD
Cefprozil—Vomiting—Capecitabine—esophageal cancer	0.0041	0.0041	CcSEcCtD
Cefprozil—Rash—Capecitabine—esophageal cancer	0.00407	0.00407	CcSEcCtD
Cefprozil—Dermatitis—Capecitabine—esophageal cancer	0.00406	0.00406	CcSEcCtD
Cefprozil—Headache—Capecitabine—esophageal cancer	0.00404	0.00404	CcSEcCtD
Cefprozil—Feeling abnormal—Methotrexate—esophageal cancer	0.00396	0.00396	CcSEcCtD
Cefprozil—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00393	0.00393	CcSEcCtD
Cefprozil—Nausea—Capecitabine—esophageal cancer	0.00383	0.00383	CcSEcCtD
Cefprozil—Urticaria—Methotrexate—esophageal cancer	0.00381	0.00381	CcSEcCtD
Cefprozil—Abdominal pain—Methotrexate—esophageal cancer	0.0038	0.0038	CcSEcCtD
Cefprozil—Body temperature increased—Methotrexate—esophageal cancer	0.0038	0.0038	CcSEcCtD
Cefprozil—Hypersensitivity—Methotrexate—esophageal cancer	0.00354	0.00354	CcSEcCtD
Cefprozil—Pruritus—Methotrexate—esophageal cancer	0.0034	0.0034	CcSEcCtD
Cefprozil—Diarrhoea—Methotrexate—esophageal cancer	0.00329	0.00329	CcSEcCtD
Cefprozil—Dizziness—Methotrexate—esophageal cancer	0.00318	0.00318	CcSEcCtD
Cefprozil—Vomiting—Methotrexate—esophageal cancer	0.00305	0.00305	CcSEcCtD
Cefprozil—Rash—Methotrexate—esophageal cancer	0.00303	0.00303	CcSEcCtD
Cefprozil—Dermatitis—Methotrexate—esophageal cancer	0.00303	0.00303	CcSEcCtD
Cefprozil—Headache—Methotrexate—esophageal cancer	0.00301	0.00301	CcSEcCtD
Cefprozil—Nausea—Methotrexate—esophageal cancer	0.00285	0.00285	CcSEcCtD
